Stock A102460 REYON PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company REYON Pharmaceutical Co., Ltd.

Equities

A102460

KR7102460003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
13,780 KRW +1.17% Intraday chart for REYON Pharmaceutical Co., Ltd. +4.47% -16.69%
Mar. 21 REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 REYON Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

REYON PHARMACEUTICAL Co. Ltd. is a Korea-based company engaged in the provision of pharmaceutical products. The Company’s products consist of remedies for circulatory systems, endocrine systems, digestive systems, respiratory systems, urinary systems and nervous systems, as well as eye drops, antibiotics, fever reducers, painkillers, anti-inflammatory drugs, antihistaminic agents, enzyme preparations, arthritis remedies, antitumor drugs and topical anesthetics, among others. It also produces pharmaceutical raw materials, such as arbekacin sulfate, alibendol, carvedilol, enocitabine, gemcitabine, glimepiride, lamotrigine, meloxicam, oxaliplatin, pioglitazone hydrochloride, ramipril, streptokinase, tacrolimus, thioctic acid, teicoplanin, voglibose and others.

Number of employees: 463

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
154,039 100.0 % 151,071 100.0 % -1.93%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.0 %
151,665 98.5 % 149,518 99.0 % -1.42%
Japan
0.6 %
1,786 1.2 % 831 0.6 % -53.46%
Vietnam
0.3 %
323 0.2 % 447 0.3 % +38.17%
Peru
0.1 %
-- 89 0.1 % -
Indonesia
0.0 %
197 0.1 % 63 0.0 % -68.02%
Mongolia
0.0 %
32 0.0 % 61 0.0 % +92.36%
Thailand
0.0 %
-- 33 0.0 % -
Hong Kong
0.0 %
18 0.0 % 17 0.0 % -2.63%
Malaysia
0.0 %
-- 12 0.0 % -

Managers

Managers TitleAgeSince
Soon-Ok Jeong CEO
 Chief Executive Officer 73 -
Yong-Hwan Yoo CEO
 Chief Executive Officer 50 -
Ju-Won Cho SAM
 Sales & Marketing 54 -

Members of the board

Members of the board TitleAgeSince
Yong-Hwan Yoo CEO
 Chief Executive Officer 50 -
Joong-Hyeop Kim BRD
 Director/Board Member 80 -
Soon-Ok Jeong CEO
 Chief Executive Officer 73 -
Seok-Ho Lee BRD
 Director/Board Member 77 -
Sung-Jun Yoon BRD
 Director/Board Member 50 -
Young-Jun Cho BRD
 Director/Board Member 53 -
Taek-Ki Hong BRD
 Director/Board Member 69 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,586,811 7,939,628 ( 42.72 %) 245,820 ( 1.323 %) 42.72 %

Shareholders

NameEquities%Valuation
Yong-Hwan Yoo
28.40 %
5,278,113 28.40 % 60 M ₩
Soon-Ok Jeong
10.06 %
1,869,899 10.06 % 21 M ₩
Jeong-min Yoo
7.561 %
1,405,307 7.561 % 16 M ₩
Soon-hee Jeong
6.825 %
1,268,478 6.825 % 14 M ₩
INTRON BIOTECHNOLOGY, INC.
1.544 %
287,000 1.544 % 3 M ₩
REYON PHARMACEUTICAL CO., LTD.
1.323 %
245,820 1.323 % 3 M ₩
Kwang-sik Jeon
0.1077 %
20,023 0.1077 % 226 816 ₩
Dimensional Fund Advisors Ltd.
0.0112 %
2,083 0.0112 % 23 596 ₩
DFA Australia Ltd.
0.005429 %
1,009 0.005429 % 11 430 ₩
Mirae Asset Global Investments Co., Ltd.
0.002088 %
388 0.002088 % 4 395 ₩
NameEquities%Valuation
Quad Investment Management Co., Ltd.
100.00 %
500,000 100.00 % 6 M ₩

Holdings

NameEquities%Valuation
REYON PHARMACEUTICAL CO., LTD.
1.32%
 245,820 1.32% 2,784,590 $
INTRON BIOTECHNOLOGY, INC.
0.14%
 47,000 0.14% 253,809 $

Company contact information

REYON PHARMACEUTICAL Co., Ltd.

8th Floor, Cosmo Tower 416 Yeongdong-daero

06176, Seoul

+

http://reyonpharm.co.kr
address REYON Pharmaceutical Co., Ltd.(A102460)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
REYON PHARMACEUTICAL CO., LTD. Stock REYON Pharmaceutical Co., Ltd.
-16.69% 184M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.62% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+13.07% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+37.46% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A102460 Stock
  4. Company REYON Pharmaceutical Co., Ltd.